HOME >> BIOLOGY >> NEWS
St. Jude shows how disorderliness in some proteins lets them interact with a diversity of molecules

Investigators at St. Jude Children's Research Hospital have demonstrated for the first time that--contrary to the long-held belief among scientists that proteins must maintain a rigid structure in order to perform an assigned task--many proteins actually exploit disorderliness in their structure to perform a variety of different jobs. The findings of this research appear in the current, online issue of Nature Structural and Molecular Biology.

The St. Jude finding explains how many of the body's proteins can adapt their structures to the needs of the moment, binding to different molecules depending on the job at hand.

"The potential importance of disorder in the function of some proteins has been discussed by researchers for several years," said Richard W. Kriwacki, PhD, associate member of the St. Jude Department of Structural Biology and senior author of the report. "But until now no one had actually demonstrated how such flexibility allows a protein to interact with different molecules. We've taken a big step in understanding the subtle details of a critical biochemical process in the life of the cell."

Previously, other researchers suggested that 30 to 40 percent of the body's proteins do not rely on a rigid structure to interact with target molecules. In the current study, the St. Jude team verified that idea by showing how a protein called p27 uses two flexible arms to help it bind to a protein complex called Cdk2-cyclin A. This interaction is important because Cdk2-cyclin A is one of the so-called "master timekeepers" of cell division. These timekeepers trigger sequential events leading to the production of new daughter cells. By binding to Cdk2-cyclin A and blocking its activity, p27 disrupts this sequence and prevents the cell from dividing. The importance of p27's role in regulating cell division is highlighted by findings showing that loss of p27 function is a key contributing factor in several types of cancer.

The researchers demonst
'"/>

Contact: Bonnie Cameron
bonnie.cameron@stjude.org
901-495-4815
St. Jude Children's Research Hospital
19-Mar-2004


Page: 1 2

Related biology news :

1. New study shows hope for treating inhalant abuse
2. Chemical derived from vitamin-E shows early promise as cancer drug
3. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
4. Trial shows which brain cancer patients benefit from temozolomide
5. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
6. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
7. Simian virus 40 not associated with non-Hodgkin lymphoma, study shows
8. A probable cause for high blood pressure identified - shows links with diabetes
9. Blue marlin in gulf have high mercury levels, A&M study shows
10. New research shows air pollution can reduce childrens lung function
11. Pneumococcal vaccine reduces ear infections, pneumonia, new study shows

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/18/2019)... ... March 18, 2019 , ... Periodontal disease, where bacterial infection of the gums ... the US population. Making this disease particularly challenging to treat is the fact ... are enmeshed in a sticky extracellular material that makes them more resistant to antibiotic ...
(Date:3/14/2019)... ... 13, 2019 , ... Bode Technology (Bode), a leading provider of forensic DNA analysis ... sexual assault kits. As thousands of untested kits are identified across the country, Bode ... . Bode has tested more than 50,000 kits in the last three years alone. ...
(Date:3/11/2019)... ... ... A new report published by the Family Equality Council reveals a strong interest ... 18 to 35 already have or are considering having children, 63% in the 36 ... LGBTQ prospective parents, 41% are considering assisted reproductive technology (ART) such as intrauterine insemination ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... ... March 14, 2019 , ... EyeCRO ... Oklahoma City, OK. EyeCRO joins the Department of Veterans Affairs, the Oklahoma Medical ... as the fifth institution in Oklahoma to receive this prestigious endorsement. The ...
(Date:3/14/2019)... ... March 13, 2019 , ... The ... Biotechnology Conference , taking place in Brussels, Belgium on 25–26 September 2019. This ... operational solutions, and innovative approaches. , “Biopharmaceuticals have become a main pillar ...
(Date:3/11/2019)... ... March 11, 2019 , ... USDM Life Sciences ... and information management with built in GxP compliance for the life sciences industry. ... GxP validation and continuous compliance for Generis’ flagship product, CARA. ...
(Date:3/4/2019)... ... ... current hot topics through free webinars presented by leading experts in pharma, biotech, medical device ... to save your place! Participate in the discussion and stay relevant in your field! , ... , March 20 – Implementing BYOD Across Phase II and III Clinical Trials ...
Breaking Biology Technology:
Cached News: